BioGaia Press releases

Latest press releases and news

View all press releases and news

BioGaia AB and University of Gothenburg discovered a new role for bacteria present in the gut: serotonin production

Often considered as our “second brain”, the human gut and its resident microbiota play a crucial bidirectional role communicating the brain (central nervous system) with the gut (enteric nervous system), in what is called the microbiota-gut-brain axis. Researchers of University of Gothenburg and BioGaia AB (NASDAQ: BIOG) have identified that specific bacteria present in the […]
Regulatory

BioGaia AB: Interim Management Statement January – September 2025

THIRD QUARTER 2025 Net sales amounted to SEK 326.6 million (304.0), an increase of SEK 22.7 million, or an increase of 7% (excluding foreign exchange effects an increase of 14%). Net sales in the Pediatrics segment amounted to SEK 242.6 million (225.8), an increase of 7% (excluding foreign exchange effects an increase of 14%). Net […]

The study on BioGaia’s new patented strain L. reuteri BG-R46® published in Beneficial Microbes

We are proud to announce that the scientific rationale and identification of our newly patented strain, Limosilactobacillus reuteri BG-R46®, has been published in the prestigious journal, Beneficial Microbes. This next-generation strain will be featured in our upcoming baby drops product. Developed by BioGaia AB (NASDAQ: BIOG) and a research team at the Swedish University of […]